Now built for real clinical use
The Clinical Intelligence Layer for modern medicine

Never walk into a room not knowing what changed.

BIOD® turns fragmented labs, patient history, longitudinal trends and encounter data into one structured clinical picture — reviewed, decided and carried forward by you, not reconstructed by you.

Built for U.S. healthcare professionals Physician-controlled decisions BAA available
In early clinical use with practicing physicians — see the results ↓
med.biod.ai · patient clinical intelligence dashboard
AM
Alex Morgan52 y · female · Blood type A+
Longitudinal patient state
ATTENTION · Ferritin trajectory declining across serial panelsView biomarkers →
ATTENTION · ApoB remains above individualized review targetView biomarkers →
ATTENTION · Persistent fatigue with incomplete recovery contextReview context →
Active problems · ranked by risk & urgencyFull history →
Progressive iron-store depletion before overt anemia

Ferritin has declined longitudinally despite preserved hemoglobin and MCV.

Primary review
ApoB-predominant atherogenic particle burden

Particle burden remains clinically relevant despite otherwise favorable metabolic regulation.

Investigating
Persistent fatigue with incomplete sleep / recovery context

Multifactorial symptom remains open because important context is still missing.

Investigating
Vitamin D insufficiency with incomplete treatment-response data

Longitudinal comparison is more useful than the current single value.

Follow-up
Medications · adherence3 active
Rosuvastatin10 mg nightlyVitamin D3dailyMagnesium glycinatenightly
Dominant risk
Progressive iron-store depletion
24Ferritin · ng/mL
Last encounter · Aug 4, 2026
Suggested return · Sep 1, 2026
↗ Pre-consultation link
Bioindicators & agingDetail →
Inflammation18
Oxidation17
Glycation15
Methylation19
Longevity16
Vitality15
Lab panel statusView all →
40 optimal
22 within range
10 out of range
Biomarkers that matter
Ferritin24 ↓
ApoB118 ↑
Vitamin D28 ↓
hs-CRP1.7
Ordered labs · awaiting result
Iron panelReticulocytesRepeat ApoB25-OH Vitamin D
Recent timeline
#ATD-0214 · last encounter
Aug 4, 2026
72 → 4markers distilled into prioritized clinical signals for review
The moment BIOD earns its place

Four "normal" results. One pattern no one had time to see.

This is a synthetic example, built to mirror what BIOD actually does with real longitudinal data: connect isolated, individually unremarkable results into a signal a physician can act on — before it becomes a bigger problem.

Four separate visits. Four "normal" ferritin results.
Visit 1 · 202361 ng/mLNormal
Visit 2 · 202444 ng/mLNormal
Visit 3 · 202531 ng/mLNormal
Visit 4 · 202624 ng/mLLow-normal
What BIOD sees across the same four visits
Progressive iron-store depletionThree years of individually "normal" results were, together, a three-year decline — surfaced before it became anemia.
Every value shown here was inside the reference range on its own. None of the four reports would have triggered a flag alone, and reconstructing this by re-reading four years of PDFs during a 15-minute visit is exactly the kind of work physicians tell us they don't have time for. This is the single most common reason early BIOD users give when asked why they keep coming back to it.
Synthetic patient example · mirrors BIOD's real longitudinal comparison logic.
Built into the encounter

Talk to your patient. Not to your screen.

BIOD listens to the visit in real time and drafts the note as the conversation happens — Subjective, Objective, Assessment, Plan — so the physician can stay present with the patient instead of typing. Nothing is final until it's reviewed: every line stays editable, and the note only locks once the physician signs it.

Live transcript

Physician: How has the fatigue been since we adjusted the dose?

Patient: Better most days, but I still crash by mid-afternoon.

Physician: Any changes in sleep, or the supplements we discussed?

Transcribing…

SOAP draft Not signed

SFatigue improved on current dose; residual mid-afternoon crash reported.

OSleep pattern and supplement adherence reviewed with patient.

APartial response to dose adjustment; fatigue not fully resolved.

PContinue current dose; reassess in 4 weeks; consider sleep evaluation if unresolved.

No typing during the visit — just the conversation.
Edit, rewrite or discard any line before you sign.
The same encounter feeds directly into Diagnostic Intelligence below — nothing is re-entered.
The centerpiece: Integrated Clinical Synthesis

BIOD doesn't just flag findings. It writes the clinical picture — and hands you the pen.

At the close of every encounter, BIOD drafts a structured synthesis: what's driving the case, what's coexisting, what's contributing, and what's background noise — with a confidence score attached. The physician edits, confirms or rewrites it. Nothing becomes part of the record until a clinician has touched it.

Clinical pictureEdited by the physician
Moderate confidence

The current picture is primarily driven by progressive iron-store depletion, with ferritin trending downward across three years of individually normal results. ApoB-predominant atherogenic burden remains a persistent secondary risk despite reassuring standard lipid values. Persistent fatigue is only partially explained by iron status — incomplete sleep and recovery context limits full attribution. Vitamin D insufficiency is a stable background finding with no treatment-response data yet.

Primary driver
Progressive iron-store depletion
Major coexisting risk
ApoB-predominant atherogenic burden
Possible contributor
Sleep / recovery deficit affecting fatigue
Background condition
Vitamin D insufficiency, response pending
3 other hypotheses assessed — 0 discarded by the physician, 3 kept open to reassess with the requested tests. Full record preserved in the audit trail.

This is the same governance logic behind every BIOD closing note: the model proposes, timestamps and shows its reasoning — the physician decides what becomes the record. The generated clinical note stays signed and immutable once finalized; any change afterward is a tracked addendum, not a silent edit.

Early BIOD results

Real physicians. Numbers we'll keep updating in public.

Internal BIOD testing with practicing clinicians during the beta period.

These are early, self-reported results from BIOD's internal testing — not a peer-reviewed study. Full methodology is one click away.
92%hypothesis concordance*Use the exact internal study definition publicly.
45%physician time saved*Observed in evaluated BIOD workflows.
45%increase in productivity*Internal beta observation.
35%increase in practice revenue*Associated with tracking, follow-through and capacity gains.
*Internal testing, self-reported. Not peer-reviewed. Individual results may vary.
The structural problem

The physician became the integration layer.

Clinical data arrives through systems built to store, document, deliver or retrieve. The synthesis still happens manually — usually at 9pm, alone, re-reading someone else's PDF, trying to remember what changed since the last visit.

Today
Tools → Physician → Decision

The physician gathers, reconciles, remembers and connects the pieces.

With BIOD
Tools → BIOD → Physician

BIOD assembles the picture. The physician spends judgment on judgment.

E
EHR

History, medications, prior decisions and documentation.

L
Lab Portals

PDFs, panels, reference ranges and repeated results.

C
Clinical Encounter

Symptoms, observations, decisions and follow-up.

D
External Data

Outside records, imaging findings and longitudinal context.

The missing layer
Clinical Synthesis

Patterns, relationships, hypotheses, missing information, evidence and prioritized action.

BIOD®
Clinical Intelligence Layer

Structured intelligence ready for clinician review — with reasoning and uncertainty visible.

The product is the pipeline

Not another place to store data. A system built to make clinical data useful.

Each stage solves a different information failure — and improves what the next stage receives.

01
I

Clinical Intake

A pre-registration link goes out automatically the first time a patient is scheduled, and a pre-consultation link before every visit after that — history, complaints and lab PDFs arrive before the physician does. Patient context enters one structured longitudinal record.

02
L

Lab Intelligence

380+ biomarkers extracted, normalized, trended and contextualized — mapped to 6 health indicators (inflammation, oxidation, glycation, methylation, longevity, vitality) and risk models for the 11 leading causes of death in the US.

03
P

Pattern Detection

Relationships across biomarkers and time become visible.

04
H

Hypotheses

Clinical hypotheses are ranked with explicit rationale.

05
E

Evidence + Gaps

Support, conflict, uncertainty and missing data are surfaced.

06

Prioritized Actions

Tests, referrals, medications and follow-up are organized.

07

Physician Decision

The clinician accepts, edits, rejects, orders or changes.

08

Follow-Through

The decision remains connected to the next encounter.

Product proof

See BIOD work through the same case, start to finish.

Synthetic patient example · mirrors the live BIOD workflow
STEP 01 · BEFORE THE VISIT

Arrive already informed.

Scheduling is not a disconnected calendar. The next clinical encounter is tied to the patient's history, prior decisions and the work that needs to be revisited.

See what BIOD finds in your own clinical workflow.

Start with real cases, reach first clinical value quickly, and decide after the platform has earned a place in your practice.

Start Free for 3 Months ↗
Why physicians stop going back to the old way

The next visit starts where this one ended.

Every encounter completed in BIOD makes the next one faster and sharper. Leaving BIOD means reconstructing that context from scratch — which is usually the moment physicians realize how much it was already doing for them.

Visit 1

Baseline context captured. Ferritin flagged as a value to watch.

Visit 2

Trend begins. BIOD compares automatically against the prior visit.

Visit 3

Pattern confirmed across three data points. Hypothesis ranked and surfaced.

Visit 4

Full longitudinal picture ready before the physician opens the chart.

Without BIOD, this context lives in memory, scattered PDFs and a chart that has to be re-read every time. In BIOD's own product language, every closing note "seeds the next pre-encounter": the patient receives a pre-consultation link by e-mail, and the next visit starts from this plan — not from zero. Your practice always retains access to the underlying record; what compounds inside BIOD is the synthesis on top of it.
Why BIOD is different

BIOD doesn't replace the clinical stack. It completes it.

Every existing category is useful. The gap appears at synthesis — where fragmented outputs must become one clinical picture before the physician can decide.

Category
What it does well
Where BIOD begins
EHR
Captures the record, billing and documentation.
Synthesizes information into a decision-ready picture.
Standalone AI Scribe tools
Documents the encounter.
BIOD includes its own AI Scribe — same real-time transcription, plus the reasoning is structured before and during the decision, not just written down after it.
Lab Portal
Delivers laboratory data and reference flags.
Connects values, trends and patient context into clinical signals.
General AI
Answers a prompt and generates text.
Works from a structured patient workflow with visible evidence and missing-data logic.
Literature Search
Retrieves evidence.
Connects relevant evidence to the current patient picture for review.
Two value stories

One platform. Two reasons to depend on it.

The clinician buys back cognitive capacity and stops being caught off guard. The practice turns synthesis into operational leverage.

For the clinician

The physician who's never caught off guard.

BIOD reduces the manual work required to bring labs, history, patterns, hypotheses, missing information and next actions into one coherent picture.

Know what changed before entering the room.
See longitudinal relationships instead of reading reports in isolation.
Review supporting, conflicting and unresolved information in one place.
Move from reasoning to orders, prescriptions, referrals and follow-up.
For the clinic owner

The owner who finally sees where capacity leaks.

BIOD's internal testing suggests that better synthesis and follow-through can improve clinical workflow and practice economics.

45%physician time saved*
45%productivity increase*
35%practice revenue increase*
Increase effective physician capacity without simply adding administrative burden.
Improve tracking of unresolved actions and patients who need follow-up.
Standardize how complex information reaches clinicians across a practice.
*Internal testing results. Individual practice results may vary.
Built for data-intensive medicine
Longevity & Preventive Medicine Functional & Integrative Medicine Concierge Medicine Internal Medicine Endocrinology & Hormone Health Cardiometabolic Medicine Dermatology + Wellness
Human authority is part of the architecture

BIOD prepares the decision. You own it.

Clinical hypotheses, evidence, uncertainty, missing context and next-step options remain visible. The clinician can accept, edit, reject, reorder or continue investigating.

Iron depletion contributing to fatigue

Evidence fit 84 · serial ferritin decline with compatible symptom context.

Investigating
Confirm for planKeep investigatingDismiss

ApoB-predominant risk signal

Evidence fit 78 · particle-burden signal despite reassuring metabolic markers.

Investigating
Review evidenceOrder nextDismiss

Medication / referral / testing

Actions remain pending until the clinician actively chooses the next step.

Clinician controlled
PrescribePrint orderCreate referral
Trust

Clinical intelligence only works if the clinician can trust the system — and challenge it.

BAA
Business Associate Agreement

BAA available as part of BIOD's HIPAA contracting framework.

MD
Professional-use workflow

BIOD is designed for clinician review and physician-controlled clinical decision-making.

EV
Full audit trail

Every hypothesis confirmed, dismissed or kept open is timestamped and preserved — not just the final note.

Longitudinal continuity

The next encounter can begin from the previous decision state instead of reconstructing the chart.

Biod.ai®
Federally registered U.S. service mark

Biod.ai® is registered in the United States.

Registered for Class 42 SaaS/PaaS services featuring artificial intelligence for laboratory analysis and diagnostic support in healthcare.

USPTO Reg. No. 8,075,271 · Registered Dec. 23, 2025
Three months to experience it in your own practice

Don't evaluate BIOD from a sales presentation.

Create an account, use BIOD inside your own clinical workflow, and decide after the value becomes visible in practice.

01Create your account
Move directly from the website into the professional platform.
02Complete your first clinical workflow
Patient context → labs → intelligence → physician action.
03BIOD success support
Your team helps with adoption and workflow fit during the free period.
04Convert after value is visible
Choose the commercial plan that fits the clinician or practice.
Create your account

Join BIOD®

Set up your professional account and start the three-month free access period.

I agree to the Terms of Service and Privacy Policy and understand the professional-use terms of the BIOD platform.
Already have an account? Sign in · Professional healthcare use
FAQ

Questions a clinician should be able to answer before registering.

No. BIOD is positioned as a clinical intelligence layer, not as a replacement for the system of record. It organizes and synthesizes information for clinician review and can coexist with the clinical systems a practice already uses.
BIOD generates and prioritizes clinical hypotheses with visible reasoning, supporting or conflicting evidence, unresolved information and next-step options. The clinician remains responsible for reviewing the information and making the clinical decision.
Yes. The current BIOD workflow supports clinician-controlled actions including laboratory orders, printable orders, prescriptions, referrals and encounter follow-through. These actions remain under clinician control.
The strongest initial fit is independent and small-to-mid-sized U.S. practices working in data-intensive clinical areas such as longevity, preventive, functional/integrative, concierge, internal medicine, endocrinology, cardiometabolic medicine and dermatology/wellness.
Your practice retains its data rights under the BAA and Terms of Service, and can export patient history at any time. What lives inside BIOD specifically is the accumulated synthesis — trends, ranked hypotheses, prioritized context — built up across visits. That layer is what most clinicians say they'd miss most if they stopped, but it never limits access to the underlying record.
Clinicians register directly through med.biod.ai/register and can begin using the platform free for three months. During the free period, the BIOD team supports onboarding, use and partnership development; commercial plans can follow after value has been demonstrated in practice.
The 92%, 45%, 45% and 35% figures come from BIOD's internal testing program with practicing clinicians. They are self-reported and not yet independently validated. The full methodology — case count, definitions, limitations — is one click away in "View full methodology."